Want to see CH:EMSN full AI Analyst Report?
EMS-CHEMIE HOLDING AG (EMSN) Ratios
2 Followers
EMS-CHEMIE HOLDING AG Ratios
CH:EMSN's free cash flow for Q2 2026 was CHF232.71M. For the 2026 fiscal year, CH:EMSN's free cash flow was decreased by CHF-11.86M and operating cash flow was CHF244.56M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.98 | 6.06 | 4.69 | 4.20 | 4.27 |
| Quick Ratio | 3.85 | 3.77 | 3.01 | 2.39 | 2.90 |
| Cash Ratio | 2.38 | 2.15 | 0.90 | 0.66 | 0.29 |
| Solvency Ratio | 1.42 | 1.42 | 1.27 | 1.24 | 1.22 |
| Operating Cash Flow Ratio | 2.12 | 1.99 | 1.97 | 2.25 | 1.20 |
| Short-Term Operating Cash Flow Coverage | 25.16 | 139.84 | 26.50 | 0.00 | 155.45 |
| Net Current Asset Value | CHF 1.15B | CHF 1.10B | CHF 976.85M | CHF 1.10B | CHF 1.13B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.02 | 0.00 | 0.02 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.02 | 0.00 | 0.02 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.20 | 1.21 | 1.24 | 1.28 | 1.29 |
| Debt Service Coverage Ratio | 22.59 | 97.44 | 21.75 | 410.57 | 145.90 |
| Interest Coverage Ratio | 374.92 | 282.55 | 279.22 | 421.82 | 510.22 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.45 | 0.46 | 1.46 | 0.64 | 0.88 |
| Net Debt to EBITDA | -0.94 | -0.84 | -0.43 | -0.36 | -0.13 |
| Profitability Margins | |||||
| Gross Profit Margin | 34.14% | 46.86% | 27.18% | 29.24% | 32.37% |
| EBIT Margin | 28.38% | 26.57% | 22.51% | 24.87% | 28.49% |
| EBITDA Margin | 31.21% | 29.14% | 24.78% | 26.96% | 30.97% |
| Operating Profit Margin | 28.38% | 26.03% | 22.50% | 24.68% | 28.05% |
| Pretax Profit Margin | 28.92% | 26.51% | 22.47% | 24.84% | 28.46% |
| Net Profit Margin | 23.95% | 22.25% | 20.90% | 21.79% | 24.42% |
| Continuous Operations Profit Margin | 24.14% | 22.51% | 21.07% | 21.90% | 24.53% |
| Net Income Per EBT | 82.82% | 83.93% | 93.02% | 87.73% | 85.81% |
| EBT Per EBIT | 101.89% | 101.84% | 99.87% | 100.63% | 101.45% |
| Return on Assets (ROA) | 20.97% | 20.69% | 21.11% | 22.97% | 23.67% |
| Return on Equity (ROE) | 25.18% | 25.11% | 26.27% | 29.30% | 30.59% |
| Return on Capital Employed (ROCE) | 28.05% | 27.14% | 26.28% | 31.04% | 32.51% |
| Return on Invested Capital (ROIC) | 23.12% | 22.96% | 24.28% | 27.30% | 27.92% |
| Return on Tangible Assets | 21.52% | 21.24% | 21.69% | 24.11% | 24.85% |
| Earnings Yield | 3.63% | 3.22% | 2.87% | 3.63% | 2.30% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.70 | 5.73 | 6.73 | 5.08 | 5.16 |
| Payables Turnover | 20.69 | 13.62 | 16.65 | 13.13 | 10.60 |
| Inventory Turnover | 2.37 | 2.00 | 3.23 | 2.55 | 2.94 |
| Fixed Asset Turnover | 3.46 | 3.49 | 3.59 | 3.93 | 3.88 |
| Asset Turnover | 0.88 | 0.93 | 1.01 | 1.05 | 0.97 |
| Working Capital Turnover Ratio | 1.57 | 1.80 | 1.92 | 2.00 | 1.92 |
| Cash Conversion Cycle | 200.24 | 219.37 | 145.38 | 187.15 | 160.41 |
| Days of Sales Outstanding | 64.02 | 63.69 | 54.21 | 71.78 | 70.75 |
| Days of Inventory Outstanding | 153.87 | 182.48 | 113.09 | 143.16 | 124.10 |
| Days of Payables Outstanding | 17.64 | 26.80 | 21.92 | 27.79 | 34.45 |
| Operating Cycle | 217.89 | 246.17 | 167.30 | 214.94 | 194.85 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 22.97 | 20.54 | 24.65 | 35.92 | 19.53 |
| Free Cash Flow Per Share | 21.77 | 19.13 | 22.54 | 31.90 | 16.12 |
| Dividend Paid and CapEx Coverage Ratio | 1.24 | 1.18 | 1.11 | 1.44 | 0.96 |
| Capital Expenditure Coverage Ratio | 19.15 | 14.62 | 11.70 | 8.94 | 5.72 |
| Operating Cash Flow Coverage Ratio | 16.53 | 54.70 | 17.83 | 62.12 | 23.54 |
| Operating Cash Flow to Sales Ratio | 0.28 | 0.23 | 0.26 | 0.34 | 0.20 |
| Free Cash Flow Yield | 3.96% | 3.13% | 3.31% | 5.10% | 1.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 27.52 | 31.04 | 34.81 | 27.52 | 43.39 |
| Price-to-Sales (P/S) Ratio | 6.59 | 6.91 | 7.28 | 6.00 | 10.60 |
| Price-to-Book (P/B) Ratio | 6.93 | 7.79 | 9.14 | 8.06 | 13.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 25.24 | 31.96 | 30.22 | 19.62 | 63.35 |
| Price-to-Operating Cash Flow Ratio | 23.92 | 29.77 | 27.63 | 17.43 | 52.27 |
| Price-to-Earnings Growth (PEG) Ratio | 20.08 | 43.37 | -2.48 | -8.30 | 1.62 |
| Enterprise Value Multiple | 20.18 | 22.85 | 28.94 | 21.88 | 34.08 |
| Enterprise Value | 12.28B | 13.79B | 15.70B | 14.41B | 23.79B |
| EV to EBITDA | 20.18 | 22.85 | 28.94 | 21.88 | 34.08 |
| EV to Sales | 6.30 | 6.66 | 7.17 | 5.90 | 10.55 |
| EV to Free Cash Flow | 24.12 | 30.82 | 29.78 | 19.31 | 63.11 |
| EV to Operating Cash Flow | 22.86 | 28.71 | 27.23 | 17.15 | 52.07 |
| Tangible Book Value Per Share | 77.04 | 77.26 | 73.17 | 74.20 | 73.46 |
| Shareholders’ Equity Per Share | 79.31 | 78.45 | 74.47 | 77.63 | 76.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.15 | 0.06 | 0.12 | 0.14 |
| Revenue Per Share | 83.37 | 88.54 | 93.59 | 104.40 | 96.36 |
| Net Income Per Share | 19.97 | 19.70 | 19.56 | 22.75 | 23.53 |
| Tax Burden | 0.83 | 0.84 | 0.93 | 0.88 | 0.86 |
| Interest Burden | 1.02 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.15 | 1.03 | 1.26 | 1.58 | 0.83 |
Currency in CHF
